Your browser doesn't support javascript.
loading
The Dynamics of Dopamine D2 Receptor-Expressing Striatal Neurons and the Downstream Circuit Underlying L-Dopa-Induced Dyskinesia in Rats / 神经科学通报·英文版
Neuroscience Bulletin ; (6): 1411-1425, 2023.
Article in En | WPRIM | ID: wpr-1010621
Responsible library: WPRO
ABSTRACT
L-dopa (l-3,4-dihydroxyphenylalanine)-induced dyskinesia (LID) is a debilitating complication of dopamine replacement therapy for Parkinson's disease. The potential contribution of striatal D2 receptor (D2R)-positive neurons and downstream circuits in the pathophysiology of LID remains unclear. In this study, we investigated the role of striatal D2R+ neurons and downstream globus pallidus externa (GPe) neurons in a rat model of LID. Intrastriatal administration of raclopride, a D2R antagonist, significantly inhibited dyskinetic behavior, while intrastriatal administration of pramipexole, a D2-like receptor agonist, yielded aggravation of dyskinesia in LID rats. Fiber photometry revealed the overinhibition of striatal D2R+ neurons and hyperactivity of downstream GPe neurons during the dyskinetic phase of LID rats. In contrast, the striatal D2R+ neurons showed intermittent synchronized overactivity in the decay phase of dyskinesia. Consistent with the above findings, optogenetic activation of striatal D2R+ neurons or their projections in the GPe was adequate to suppress most of the dyskinetic behaviors of LID rats. Our data demonstrate that the aberrant activity of striatal D2R+ neurons and downstream GPe neurons is a decisive mechanism mediating dyskinetic symptoms in LID rats.
Subject(s)
Key words
Full text: 1 Index: WPRIM Main subject: Dopamine / Levodopa / Oxidopamine / Receptors, Dopamine D2 / Corpus Striatum / Parkinsonian Disorders / Dyskinesia, Drug-Induced / Neurons / Antiparkinson Agents Limits: Animals Language: En Journal: Neuroscience Bulletin Year: 2023 Type: Article
Full text: 1 Index: WPRIM Main subject: Dopamine / Levodopa / Oxidopamine / Receptors, Dopamine D2 / Corpus Striatum / Parkinsonian Disorders / Dyskinesia, Drug-Induced / Neurons / Antiparkinson Agents Limits: Animals Language: En Journal: Neuroscience Bulletin Year: 2023 Type: Article